Monday, August 31, 2026

CDW Corporation Stock Went Down By Over 13% So Far Today

CDW Corporation Stock Went Down By Over 13% So Far Today

(VIANEWS) - Shares of CDW Corporation (NASDAQ: CDW) dropped by a staggering 13.52% to $164.56 at 11:22 EST on Wednesday, after two consecutive sessions in a row of gains. NASDAQ is falling 0.56% to $12,085.91, following the last session's downward trend. This seems, up until now, a somewhat bearish trend trading session today.

CDW Corporation's last close was $190.29, 11.49% below its 52-week high of $215.00.

About CDW Corporation

CDW Corporation provides information technology (IT) solutions in the United States, the United Kingdom, and Canada. It operates through three segments: Corporate, Small Business, and Public. The company offers discrete hardware and software products and services, as well as integrated IT solutions, including on-premise, hybrid, and cloud capabilities across hybrid infrastructure, digital experience, and security. Its hardware products comprise notebooks/mobile devices, network communications, desktop computers, video monitors, enterprise and data storage, and others; and software products consists of application suites, security, virtualization, operating systems, and network management. The company also provides advisory and design, software development, implementation, managed, professional, configuration, partner, and telecom services, as well as warranties; delivers and manages mission critical software, systems, and network solutions; and implementation and installation, and repair services to its customers through various third-party service providers. It serves government, education, and healthcare customers; and small, medium, and large business customers. CDW Corporation was founded in 1984 and is headquartered in Vernon Hills, Illinois.

Earnings Per Share

As for profitability, CDW Corporation has a trailing twelve months EPS of $8.13.

PE Ratio

CDW Corporation has a trailing twelve months price to earnings ratio of 20.24. Meaning, the purchaser of the share is investing $20.24 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 96.54%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Feb 22, 2023, the estimated forward annual dividend rate is 2.36 and the estimated forward annual dividend yield is 1.26%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is 3.2% and 3.2%, respectively.

Sales Growth

CDW Corporation's sales growth is negative 6.5% for the present quarter and negative 3.1% for the next.

Volatility

CDW Corporation's last week, last month's, and last quarter's current intraday variation average was 0.30%, 0.12%, and 1.21%.

CDW Corporation's highest amplitude of average volatility was 0.90% (last week), 1.12% (last month), and 1.21% (last quarter).

More news about CDW Corporation (CDW).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com